Modulation of small molecule solubility and protein binding by arginine

Molecular Medicine Reports

Volumn 3, Issue 5, 2010, Pages 833-836

  Arakawa, Tsutomu ^a   Uozaki, Misao ^b   Koyama, A Hajime ^b  

^a ALLIANCE PROTEIN LABORATORIES   (United States)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acycloguanosine; Arginine; Bovine serum albumin; Octyl gallate; Solubility

Indexed keywords

ACICLOVIR; ARGININE; BOVINE SERUM ALBUMIN; GALLIC ACID; GALLIC ACID OCTYL ESTER; UNCLASSIFIED DRUG;

ARTICLE; DRUG PROTEIN BINDING; DRUG SOLUBILITY; PH MEASUREMENT;

BOVINAE;

EID: 78049515820     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.331     Document Type: Article

References (21)

1. Arakawa T, Kita Y and Koyama AH: Solubility enhancement of gluten and organic compounds by arginine. Int J Pharm 355: 220-223, 2008.
2. Hirano A, Arakawa T and Shiraki K: Arginine increases the solubility of coumarin: comparison with salting-in and salting-out additives. J Biochem 144: 363-369, 2008.
3. Arakawa T and Tsumoto K: The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun 304: 148-152, 2003. (Pubitemid 36434209)
4. Arakawa T, Kita Y, Tsumoto K, Ejima D and Fukada H: Aggregation suppression of proteins by arginine during thermal unfolding. Protein Pept Lett 13: 921-927, 2006. (Pubitemid 44379784)
5. Coen DM and Richman DD: Antiviral agents. In: Fields Virology. 5th edition. Knipe DM, Howley PM, Griffin DE, Ramb RA, Straus SE, Martin MA and Roizman B (eds). Lippincott-Raven, New York, pp447-485, 2007.
6. Golovanov AP, Hautbergue GM, Wilson SA and Lian LY: Simple method for improving protein solubility and long-term stability. J Am Chem Soc 126: 8933-8939, 2004.
7. Otagiri M: Study on binding of drug to serum proteins. Yakugaku Zasshi 129: 413-425, 2009.
8. Sudlow G, Birkett DJ and Wadem DN: Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol. Clin Exp Pharmacol Physiol 2: 129-140, 1975.
9. Sudlow G, Birkett DJ and Wadem DN: Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12: 1052-1061, 1976.
10. Yamasaki K, Maruyama T, Kragh-Hansen U and Otagiri M: Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim Biophys Acta 1295: 147-157, 1996. (Pubitemid 26233243)
11. Maruyama T, Lin CC, Yamasaki K, Miyoshi T, Imai T, Yamasaki M and Otagiri M: Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group. Biochem Pharmacol 45: 1017-1026, 1993.
12. Kragh-Hansen U, Watanabe H, Nakajou K, Iwao Y and Otagiri M: Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. J Mol Biol 363: 702-712, 2006.
13. Uozaki M, Yamasaki H, Katsuyama Y, Higuchi M, Higuchi T and Koyama AH: Antiviral effect of octyl gallate against DNA and RNA viruses. Antiviral Res 73: 85-91, 2007. (Pubitemid 46135766)
14. Koyama AH and Uchida T: Inhibition by Brefeldin A of the development of nucleocapsids in herpes simplex virus type 1-infected Vero cells. Arch Virol 135: 305-317, 1994. (Pubitemid 2068535)
15. Arakawa T and Timasheff SN: The mechanism of action of Na glutamate, lysine HC1, and piperazine-N,N′-bis(2-ethanesulfonic acid) in the stabilization of tubulin and microtubule formation. J Biol Chem 259: 4979-4986, 1984.
16. Arakawa T, Kita Y and Narhi LO: Hydrophobic interaction chromatography in alkaline pH. Anal Biochem 182: 266-270, 1989.
17. Kita Y, Arakawa T, Lin TY and Timasheff SN: Contribution of the surface free energy perturbation to protein-solvent interaction. Biochemistry 33: 15178-15189, 1994.
18. Arakawa T, Ejima D, Tsumoto K, Obeyama N, Tanaka Y, Kita Y and Timasheff SN: Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. Biophys Chem 127: 1-8, 2007.
19. Das U, Hariprasad G, Ethayathulla AS, Manral P, Das TK, Pasha S, Mann A, Ganguli M, Verma AK, Bhat R, Chandrayan SK, Ahmed S, Sharma S, Kaur P, Singh TP and Srinivasan A: Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key. PLoS ONE 14: 1-9, 2007.
20. Watanabe H, Tanase S, Nakajou K, Maruyama T, Kragh-Hansen U and Otagiri M: Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem J 349: 813-819, 2000. (Pubitemid 30609413)
21. Watanabe H, Kragh-Hansen U, Tanase S, Nakajou K, Mitarai M, Iwao Y, Maruyama T and Otagiri M: Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem J 357: 269-274, 2001. (Pubitemid 32642926)